Dr. Volodymyr Labinskyy, MD

Dr. Labinskyy practices at Good Samaritan University Hospital St. Charles Campus in Port Jefferson, New York, part of Diocese of Rockville Centre.

Dr. Labinskyy's NPI, 1538317334, was assigned on September 4, 2008. Dr. Labinskyy holds Massachusetts license 268517.

Dr. Labinskyy's primary practice is Good Samaritan University Hospital St. Charles Campus, at 200 Belle Terre Road, Port Jefferson, NY 11777 in Suffolk County. The practice phone is (631) 474-6000.

Dr. Labinskyy's primary practice is Good Samaritan University Hospital St. Charles Campus in Port Jefferson, New York, part of Diocese of Rockville Centre. Dr. Labinskyy is also affiliated with Mather Hospital. The medical group on file is Suffolk Vascular & Vein Center. Dmand AI also links Dr. Labinskyy to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Labinskyy practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Labinskyy's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Labinskyy is licensed in Massachusetts.

CMS data shows 1,744 Medicare services from Dr. Labinskyy across 24 procedure codes in 2024, for 443 Medicare patients. Medicare paid $195,379 for them.

CMS counts 443 Medicare patients who saw Dr. Labinskyy in 2024. The largest group is 75 to 84, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Labinskyy's median patient age at 70, with 45% women.

In 2024, Dr. Labinskyy wrote 304 Medicare Part D claims for 123 patients. 83% of them were for generic drugs. CMS names the drug for 236 of them, across 11 drugs with 11 or more claims each, at $26,084 in total drug cost. In 2023, CMS named 173 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Labinskyy for performance year 2024, reported as part of a group. Dr. Labinskyy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of varicose vein removal by Dr. Labinskyy, more than 58% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Labinskyy in 2015. Dr. Labinskyy's most frequent co-authors are Leonard Young Lee, MD and Saum Amir Rahimi, MD.

CMS Open Payments shows 210 general payments to Dr. Labinskyy from 22 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 71% of the total. AngioDynamics, Inc. paid the most, $17,538.